New Long-Term Care Pharmacy Study Highlights Unrecognized Outcomes and Cost Related to Patient Rx Interventions
FLORHAM PARK, N.J., July 23, 2020 /PRNewswire/ -- Managed Health Care Associates, Inc. (MHA), a leading health care services and software company focused on the alternate site health care provider marketplace, is excited to announce the release of new study titled "The Value of the Long-Term Care Pharmacist in the Delivery and Continuum of Care."
Authored with input from the MHA Long-Term Care Pharmacy Advisory Board, Membership, and Business Partners, this comprehensive study marks the first collaborative effort produced to help long-term care pharmacies overcome legacy barriers and achieve formal recognition of their role, value and cost to deliver care and value for the benefit of highly vulnerable patients with complex needs, as well as PBMs, Health Plans, pharmaceutical companies and other industry stakeholders. The lack of clear understanding and recognition has never been more evident than during the current pandemic. The study includes "My Pandemic Response" stories submitted by MHA member pharmacies, in addition to:
The study also marks the first release of MHA member Medication Adherence Rate Trends for both skilled nursing and assisted living settings, to hopefully establish a foundation for industry benchmarking going forward. MHA is committed to leveraging this data on behalf of the long-term care pharmacy industry, in order to understand the total economic value of these outcomes to all stakeholders and the health system in general.
The study and associated published articles will be available to MHA members.
Joe Whitt, President and CEO of PCA Pharmacy, a member of the MHA Long-Term Care Pharmacy Advisory Board, comments, "We are proud to have PCA Pharmacy be part of this new study and the opportunity to showcase our Meds to Home program and the great outcomes it is generating. PCA is appreciative of MHA's effort to move the industry forward in recognition of these types of programs and outcomes but also the type of investment we are making in support of the country's most acute patients."
Diane Koontz, MHA President, adds, "We are thrilled to publish this important study to help our members advocate for the value delivered by long-term care pharmacies, not least given the challenging pandemic conditions we all face today. The truly impressive Medication Adherence metrics and the outcomes illustrate the value driven by our members' Rx interventions – and spotlights the need for this additional value to be appropriately recognized."
For More Information Contact:
View original content to download multimedia:http://www.prnewswire.com/news-releases/new-long-term-care-pharmacy-study-highlights-unrecognized-outcomes-and-cost-related-to-patient-rx-interventions-301099189.html
SOURCE Managed Health Care Associates, Inc. (MHA)
Scaling Use Case
Utilizing Machine Learning to Predict Public Transportation Times
Real-time Insights: A Case Study for the Next Generation of Smart Construction Ecosystem